CPG2 Management of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline

Program: Clinical Practice Guidelines
Clinical Session
Saturday, March 7, 2015: 5:00 PM-6:00 PM
Hall G (San Diego Convention Center)
**This session is eligible for CME credit**

Supported by Corcept Therapeutics Incorporated, Noven Pharmaceuticals, Inc. and Pfizer, Inc.

Paul M Stewart, MD FRCP, University of Leeds, Leeds, United Kingdom
Stefan Richard Bornstein, MD, PhD, Technische Universitšt Dresden, Dresden, Germany
Task Force Participants:
Wiebke Arlt, MD, DSc, FRCP, FMedSci, University of Birmingham, Birmingham, United Kingdom , Constantine A Stratakis, MD, National Insitutes of Health, Rockville, MD , Deborah P. Merke, MS, MD, National Institutes of Health, Bethesda, MD , Eystein Sverre Husebye, MD, PhD, University of Bergen, Bergen, Norway , David J Torpy, MBBS, FRACP, PhD, Royal Adelaide Hospital, Adelaide, Australia and Andrew C Don-Wauchope, MB.BCh, MD, FRCP Edin, FCPath, FRCPath, FRCPC, McMaster University, Hamilton, Canada

WA: Consultant, Diurnal. DPM: Principal Investigator, Diurnal, Principal Investigator, Medtronic Minimed. Nothing to Disclose: SRB, PMS, CAS, ESH, DJT, ACD